• Home
  • Posts RSS
  • Comments RSS
  • Edit
Blue Orange Green Pink Purple

Experimental Drug Therapies

This blog is designed to cover the current controversy regarding experimental drug therapies. New drugs that are developed must go through a safety process. However, there are "compassionate use" exceptions made for seriously ill patients when no other treatments are effective. As future nurses/health-care workers, we need to be educated on this issue to be able to keep up with advancing medical science to be better advocates for our patients.

We hope that by reading this blog, we can provide you information on both sides of the issue so that you can form your own opinion on the topic. We also invite you to participate in our discussion by commenting on any of the posts!

How a Clinical Trial Works

How a Clinical Trial Works

The process of getting a drug on the market is an extensive process. Before clinical trials, the new treatment has to have laboratory findings (first in cells then animals) and then it has to be approved by the Health Ethics Committee. If the study is approved it will go into three phases of clinical trials:


Phase I (20 - 80 patients) Tests for safety using healthy individuals, and can lasts about two years.

Phase II (100 - 300 patients) Tests safety, dosing, and efficacy. This is administered to a target population.

Phase III (1,000 - 3,000 patients) Tests safety, efficacy, and side effects.

Typically there are multiple trials for each drug. In the 1980s a drug had an average of 30 clinical trials and involved about 1500 patients. By the 1990s these numbers more than doubled to an average of 60 trials per drug and involving nearly 5,000 patients.

After the phase III the drug manufacturer files a New Drug Application (NDA) and the FDA reviews the trials case. This process takes about two years.

Types of Trials

Diagnostic Trials: Used to find better testing procedures for a diagnosing disease.

Prevention Trials: Finds ways to prevent disease in healthy individuals or prevent the disease from returning. This includes vaccines, medicines, vitamins, minerals, or changes in lifestyle.

Quality of Life Trials: Look for ways to help improve the quality and comfort of life inpeople with chronic illnesses.

Screening Trials: Test the most effective way for detecting a certain disease.

Treatment Trials: Test experimental treatments, new approaches to surgery or radiation, or new drug combination therapies.

That’s all great, but why should I care?

Every drug that is on the market has to go through these procedures. It is a process that averages about nine years from start to finish. A lot of people don’t have that kind of time to wait for drugs to enter the market. It is also important because if a drug therapy isn’t ethical and somehow passes FDA regulations, then it is you the consumer that suffers the consequences.


It is sometimes easy to think that drugs that have not been approved by the FDA are better. Individuals who may participate in an experimental drug therapy need to be aware that there are a lot of risks, such as: (1) Suffering from adverse long-term or short-term side effects that could possibly be life-threatening, (2) the drug therapy may not be effective, (3) patient may be taking the placebo and not be receiving any medication, (4) it may require a lot more time and energy than it would to be taking a drug that is already on the market. Before going into a study make sure that you have enough information going into it.

References:

Photo: 2007- CNN Money

Daniel B. Klein, Alexander Tabarrok 2009 fdareview.org

U.S. National Institutes of Health 2007 clinicaltrials.gov


Read More 3 comments | Posted by blogpharm edit post

3 comments

  1. Sue Guinn, RN on October 29, 2009

    It does seem lengthy and I'm sure it IS costly. That is reflected in the extremely high cost of medication. It is too bad that the rest of the world doesn't have to obsorb some of these cost along with Americans. Mexico and Canada don't seem to have to pay as much as we do in the good old USA!

     
  2. Sue Guinn, RN on October 29, 2009

    I was looking for an artical I had read that relates to this subject of high cost of medication and how the drug companies use this to their advantage in some cases. It is a look at how Prilosec was altered to become Nexium. The company knew that their money making drug would be going generic and they didn't want to loose their cash cow, so they took out one of the ingredience and resubmitted it to the FDA. Since Prilosec was already approved they didn't have to start from scratch with the whole drug study program. They just had to prove that Nexium was more effective. The study showed that Nexium was a slight improvement with 90% over Prilosec with 87%. Nexium was approved and is one of the nations top selling drug.The drugs are virtually the same.
    This is what is wrong with the high cost of medications. To see the article go "The New Yorker" Archives of 2004.

     
  3. blogpharm on October 29, 2009

    Sue, you have an excellent point. I recommend that you check out our links on the side bar to one of our classmates pharmacology blog. It deals specifically with the high cost of prescription drugs.

     


Post a Comment

Newer Post Older Post Home

UTA Pharmacology

  • Authors
      Max Flores, Stacie Guinn, Ryan Wencl
  • Links

    • Clinical Trials - Government
    • Society for Clinical Trials
    • Abilgail Alliance
    • Join a clinical trial
    • FDA

    Blog Archive

    • ▼  2009 (10)
      • ▼  October (10)
        • In Conclusion...
        • CBS News - H1N1 Experimental Drug
        • Considerations to experimental drug therapies
        • LIfe-threatening Drug Back on Market - Is it Worth...
        • Cancer Drug Not used to Fight Cancer?
        • Interview with an Experimental Drug Patient
        • “No seriously ill person should have to die merely...
        • How a Clinical Trial Works
        • Brief History of Experimental Drugs
        • Welcome!!!

    Experimental Drug Terminology


    CONTROL GROUP: The standard by which experimental observations are evaluated. In many clinical trials, one group of patients will be given an experimental drug or treatment, while the control group is given either a standard treatment for the illness or a placebo.

    DOUBLE-BLIND STUDY: A clinical trial design in which neither the participating individuals nor the study staff knows which participants are receiving the experimental drug and which are receiving a placebo (or another therapy). Double-blind trials are thought to produce objective results, since the expectations of the doctor and the participant about the experimental drug do not affect the outcome; also called double-masked study.

    DRUG-DRUG INTERACTION: A modification of the effect of a drug when administered with another drug. The effect may be an increase or a decrease in the action of either substance, or it may be an adverse effect that is not normally associated with either drug.

    EXPERIMENTAL DRUG: A drug that is not FDA licensed for use in humans, or as a treatment for a particular condition

    INFORMED CONSENT: The process of learning the key facts about a clinical trial before deciding whether or not to participate. It is also a continuing process throughout the study to provide information for participants. To help someone decide whether or not to participate, the doctors and nurses involved in the trial explain the details of the study.

    OFF-LABEL USE: A drug prescribed for conditions other than those approved by the FDA.

    PLACEBO: A placebo is an inactive pill, liquid, or powder that has no treatment value. In clinical trials, experimental treatments are often compared with placebos to assess the treatment's effectiveness

    PLACEBO EFFECT: A physical or emotional change, occurring after a substance is taken or administered, that is not the result of any special property of the substance. The change may be beneficial, reflecting the expectations of the participant and, often, the expectations of the person giving the substance.

    RANDOMIZATION:A method based on chance by which study participants are assigned to a treatment group. Randomization minimizes the differences among groups by equally distributing people with particular characteristics among all the trial arms. The researchers do not know which treatment is better. From what is known at the time, any one of the treatments chosen could be of benefit to the participan.

    SIDE EFFECTS:Any undesired actions or effects of a drug or treatment. Negative or adverse effects may include headache, nausea, hair loss, skin irritation, or other physical problems. Experimental drugs must be evaluated for both immediate and long-term side effects

    Other UTA Pharmacology Blogs

    • Prescription Drugs... In Our Drinking Water?
      Prescription drugs found in tap water 2009
      16 years ago
    • Nanobano's Blog
      Epilogue
      16 years ago
    • Do medications cause suicide ?
      The History of Antidepressants
      16 years ago
    • "Miracle" Weight Loss Pills
      Pros and Cons of Weight Loss Pills
      16 years ago
    • When You Can't Afford Your Medication
      In Conclusion
      16 years ago
    • Beta Blockers: Risks Versus Benefits
      A Note to our Audience
      16 years ago
    • Pharmacology in Nursing Practice
  • Search






    • Home
    • Posts RSS
    • Comments RSS
    • Edit

    © Copyright Experimental Drug Therapies. All rights reserved.
    Designed by FTL Wordpress Themes | Bloggerized by FalconHive.com
    brought to you by Smashing Magazine

    Back to Top